BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yong YK, Tan HY, Saeidi A, Wong WF, Vignesh R, Velu V, Eri R, Larsson M, Shankar EM. Immune Biomarkers for Diagnosis and Treatment Monitoring of Tuberculosis: Current Developments and Future Prospects. Front Microbiol 2019;10:2789. [PMID: 31921004 DOI: 10.3389/fmicb.2019.02789] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Nogueira BMF, Krishnan S, Barreto‐duarte B, Araújo‐pereira M, Queiroz ATL, Ellner JJ, Salgame P, Scriba TJ, Sterling TR, Gupta A, Andrade BB. Diagnostic biomarkers for active tuberculosis: progress and challenges. EMBO Mol Med 2022. [DOI: 10.15252/emmm.202114088] [Reference Citation Analysis]
2 Daniel EA, Sathiyamani B, Thiruvengadam K, Vivekanandan S, Vembuli H, Hanna LE. MicroRNAs as diagnostic biomarkers for Tuberculosis: A systematic review and meta- analysis. Front Immunol 2022;13:954396. [DOI: 10.3389/fimmu.2022.954396] [Reference Citation Analysis]
3 Ma C, Wu X, Zhang X, Liu X, Deng G. Heme oxygenase-1 modulates ferroptosis by fine-tuning levels of intracellular iron and reactive oxygen species of macrophages in response to Bacillus Calmette-Guerin infection. Front Cell Infect Microbiol 2022;12:1004148. [DOI: 10.3389/fcimb.2022.1004148] [Reference Citation Analysis]
4 Gumbo R, Sylvester TT, Parsons SDC, Buss PE, Warren RM, van Helden PD, Miller MA, Kerr TJ. Comparison of interferon gamma release assay and CXCL9 gene expression assay for the detection of Mycobacterium bovis infection in African lions (Panthera leo). Front Cell Infect Microbiol 2022;12:989209. [DOI: 10.3389/fcimb.2022.989209] [Reference Citation Analysis]
5 Maphalle LNF, Michniak-kohn BB, Ogunrombi MO, Adeleke OA. Pediatric Tuberculosis Management: A Global Challenge or Breakthrough? Children 2022;9:1120. [DOI: 10.3390/children9081120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tomov G, Voynov P, Bachurska S. Granulomatous Cheilitis or Tuberculid? Antibiotics 2022;11:522. [DOI: 10.3390/antibiotics11040522] [Reference Citation Analysis]
7 Nathella PK, Moideen K, Viswanathan V, Sivakumar S, Ahamed SF, Ponnuraja C, Hissar S, Kornfeld H, Babu S. Heightened microbial translocation is a prognostic biomarker of recurrent tuberculosis. Clin Infect Dis 2022:ciac236. [PMID: 35352112 DOI: 10.1093/cid/ciac236] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Heyckendorf J, Georghiou SB, Frahm N, Heinrich N, Kontsevaya I, Reimann M, Holtzman D, Imperial M, Cirillo DM, Gillespie SH, Ruhwald M; UNITE4TB Consortium. Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies. Clin Microbiol Rev 2022;:e0022721. [PMID: 35311552 DOI: 10.1128/cmr.00227-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Serena NN, Boschero RA, Santiani MH, Pacce VD, Costa JMDV, Magalhães FB, Wiedmar C, Alban SM, Soccol CR, Soccol VT. High-performance immune diagnosis of tuberculosis: Use of phage display and synthetic peptide in an optimized experimental design. J Immunol Methods 2022;:113242. [PMID: 35182576 DOI: 10.1016/j.jim.2022.113242] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Goswami S, Kumar V, Chakraborty J. Computational biology and biosensors as surveillance tools for emerging and re-emerging infectious diseases. Biosensors for Emerging and Re-Emerging Infectious Diseases 2022. [DOI: 10.1016/b978-0-323-88464-8.00018-x] [Reference Citation Analysis]
11 Ivaturi N, Sashindran V, Singh A, Aggarwal V. Cytokine response to antitubercular therapy in patients with human immunodeficiency virus and tuberculosis coinfection with respect to CD4 count and viral load − A pilot study. J Mar Med Soc 2022;24:138. [DOI: 10.4103/jmms.jmms_153_21] [Reference Citation Analysis]
12 Husain AA, Nayak AR, Jain RK, Daginawala HF, Tumane R, Jawade A, Pingle S, Kashyap RS. Tuberculosis in Mine Workers: Advances in Current Diagnostic Landscape. Springer Geology 2022. [DOI: 10.1007/978-3-030-99495-2_3] [Reference Citation Analysis]
13 Muefong CN, Owolabi O, Donkor S, Charalambous S, Mendy J, Sey ICM, Bakuli A, Rachow A, Geldmacher C, Sutherland JS. Major Neutrophil-Derived Soluble Mediators Associate With Baseline Lung Pathology and Post-Treatment Recovery in Tuberculosis Patients. Front Immunol 2021;12:740933. [PMID: 34887853 DOI: 10.3389/fimmu.2021.740933] [Reference Citation Analysis]
14 Carranza C, Herrera MT, Guzmán-Beltrán S, Salgado-Cantú MG, Salido-Guadarrama I, Santiago E, Chávez-Galán L, Gutiérrez-González LH, González Y. A Dual Marker for Monitoring MDR-TB Treatment: Host-Derived miRNAs and M. tuberculosis-Derived RNA Sequences in Serum. Front Immunol 2021;12:760468. [PMID: 34804048 DOI: 10.3389/fimmu.2021.760468] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Khambati N, Olbrich L, Ellner J, Salgame P, Song R, Bijker EM. Host-Based Biomarkers in Saliva for the Diagnosis of Pulmonary Tuberculosis in Children: A Mini-Review. Front Pediatr 2021;9:756043. [PMID: 34760853 DOI: 10.3389/fped.2021.756043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Januarie KC, Uhuo OV, Iwuoha E, Feleni U. Recent advances in the detection of interferon-gamma as a TB biomarker. Anal Bioanal Chem 2021. [PMID: 34665279 DOI: 10.1007/s00216-021-03702-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Campelo TA, Cardoso de Sousa PR, Nogueira LL, Frota CC, Zuquim Antas PR. Revisiting the methods for detecting Mycobacterium tuberculosis: what has the new millennium brought thus far? Access Microbiol 2021;3:000245. [PMID: 34595396 DOI: 10.1099/acmi.0.000245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Alvarez AH. Revisiting tuberculosis screening: An insight to complementary diagnosis and prospective molecular approaches for the recognition of the dormant TB infection in human and cattle hosts. Microbiol Res 2021;252:126853. [PMID: 34536677 DOI: 10.1016/j.micres.2021.126853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chendi BH, Tveiten H, Snyders CI, Tonby K, Jenum S, Nielsen SD, Hove-Skovsgaard M, Walzl G, Chegou NN, Dyrhol-Riise AM. CCL1 and IL-2Ra differentiate Tuberculosis disease from latent infection Irrespective of HIV infection in low TB burden countries. J Infect 2021:S0163-4453(21)00379-0. [PMID: 34333033 DOI: 10.1016/j.jinf.2021.07.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kim HW, Shin AY, Ha JH, Ahn JH, Kang HS, Kim JS. Effect of serum isoniazid level on treatment outcomes among tuberculosis patients with slow response - A retrospective cohort study. J Infect Chemother 2021:S1341-321X(21)00177-X. [PMID: 34238662 DOI: 10.1016/j.jiac.2021.06.016] [Reference Citation Analysis]
21 Uno S, Nishimura T, Nishio K, Kohsaka A, Tamizu E, Nakano Y, Kagyo J, Nakajima Y, Arai R, Hasegawa H, Arakawa K, Kashimura S, Ishii R, Miyazaki N, Uwamino Y, Hasegawa N. Potential biomarker enhancing the activity of tuberculosis, hsa-miR-346. Tuberculosis (Edinb) 2021;129:102101. [PMID: 34144376 DOI: 10.1016/j.tube.2021.102101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Comella-Del-Barrio P, Izquierdo-Garcia JL, Gautier J, Doresca MJC, Campos-Olivas R, Santiveri CM, Muriel-Moreno B, Prat-Aymerich C, Abellana R, Pérez-Porcuna TM, Cuevas LE, Ruiz-Cabello J, Domínguez J. Urine NMR-based TB metabolic fingerprinting for the diagnosis of TB in children. Sci Rep 2021;11:12006. [PMID: 34099838 DOI: 10.1038/s41598-021-91545-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
23 Ambreen A, Khaliq A, Naqvi SZH, Tahir A, Mustafa M, Chaudhary SU, Mirza S, Mustafa T. Host biomarkers for monitoring therapeutic response in extrapulmonary tuberculosis. Cytokine 2021;142:155499. [PMID: 33799008 DOI: 10.1016/j.cyto.2021.155499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Acharya MP, Pradeep SP, Murthy VS, Chikkannaiah P, Kambar V, Narayanashetty S, Burugina Nagaraja S, Niveditha D, Yoganand R, Satchidanandam V. CD38 +CD27 -TNF-α + on Mtb-specific CD4 + T is a robust biomarker for tuberculosis diagnosis. Clin Infect Dis 2021:ciab144. [PMID: 33606026 DOI: 10.1093/cid/ciab144] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
25 Kanabalan RD, Lee LJ, Lee TY, Chong PP, Hassan L, Ismail R, Chin VK. Human tuberculosis and Mycobacterium tuberculosis complex: A review on genetic diversity, pathogenesis and omics approaches in host biomarkers discovery. Microbiol Res 2021;246:126674. [PMID: 33549960 DOI: 10.1016/j.micres.2020.126674] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
26 Kusnir P, Dohal M, Porvaznik I, Mokry J. Serum Inflammation Markers in Tuberculosis. Acta Medica Martiniana 2020;20:103-13. [DOI: 10.2478/acm-2020-0012] [Reference Citation Analysis]
27 Kim HW, Myong JP, Kim JS. Estimating the burden of nosocomial exposure to tuberculosis in South Korea, a nationwide population based cross-sectional study. Korean J Intern Med 2020. [PMID: 33327686 DOI: 10.3904/kjim.2020.144] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Paik S, Yang M, Suh H, Jo E. The Roles of Chemokines in Immune Response to Mycobacterial Infection. jbv 2020;50:203-17. [DOI: 10.4167/jbv.2020.50.4.203] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Lai LY, Hsu LY, Weng SH, Chung SE, Ke HE, Lin TL, Hsieh PF, Lee WT, Tsai HY, Lin WH, Jou R, Wang JT. A Glutamine Insertion at Codon 432 of RpoB Confers Rifampicin Resistance in Mycobacterium tuberculosis. Front Microbiol 2020;11:583194. [PMID: 33193223 DOI: 10.3389/fmicb.2020.583194] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Taneja V, Goel M, Shankar U, Kumar A, Khilnani GC, Prasad HK, Prasad GBKS, Gupta UD, Sharma TK. An Aptamer Linked Immobilized Sorbent Assay (ALISA) to Detect Circulatory IFN-α, an Inflammatory Protein among Tuberculosis Patients. ACS Comb Sci 2020;22:656-66. [PMID: 33063508 DOI: 10.1021/acscombsci.0c00108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
31 Müller C, Rumetshofer R, Winkler HM, Bécède M, Kneussl M, Winkler S. Loss of T cells expressing CD27 at the site of active tuberculosis - A prospective diagnostic study. Tuberculosis (Edinb) 2020;125:102009. [PMID: 33132118 DOI: 10.1016/j.tube.2020.102009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Jakhar S, Bitzer AA, Stromberg LR, Mukundan H. Pediatric Tuberculosis: The Impact of "Omics" on Diagnostics Development. Int J Mol Sci 2020;21:E6979. [PMID: 32977381 DOI: 10.3390/ijms21196979] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
33 Acharya MP, Pradeep SP, Murthy VS, Chikkannaiah P, Kambar V, Narayanashetty S, Nagaraja SB, Niveditha, Yoganand R, Satchidanandam V. CD38+CD27 on Mtb-specific CD4+ T cells distinguishes latent from active tuberculosis.. [DOI: 10.1101/2020.08.26.20180539] [Reference Citation Analysis]
34 Li L, Lv J, He Y, Wang Z. Gene network in pulmonary tuberculosis based on bioinformatic analysis. BMC Infect Dis 2020;20:612. [PMID: 32811479 DOI: 10.1186/s12879-020-05335-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Phan LMT, Kim EB, Cheon SA, Shim TS, Kim H, Park TJ. Reliable naked-eye detection of Mycobacterium tuberculosis antigen 85B using gold and copper nanoshell-enhanced immunoblotting techniques. Sensors and Actuators B: Chemical 2020;317:128220. [DOI: 10.1016/j.snb.2020.128220] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
36 Estévez O, Anibarro L, Garet E, Pallares Á, Pena A, Villaverde C, Del Campo V, González-Fernández Á. Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection. PLoS One 2020;15:e0235859. [PMID: 32687494 DOI: 10.1371/journal.pone.0235859] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
37 Kaforou M. Screening for candidate biomarkers of TB in stimulated blood: another step in the quest for a test? Thorax 2020;75:534-5. [PMID: 32522761 DOI: 10.1136/thoraxjnl-2020-214775] [Reference Citation Analysis]
38 Kaewseekhao B, Roytrakul S, Yingchutrakul Y, Salao K, Reechaipichitkul W, Faksri K. Proteomic analysis of infected primary human leucocytes revealed PSTK as potential treatment-monitoring marker for active and latent tuberculosis. PLoS One 2020;15:e0231834. [PMID: 32298370 DOI: 10.1371/journal.pone.0231834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]